SAKARPharmaceuticals

Sakar Healthcare LtdQuarterly Results & Earnings

498.45
-2.69%
Profit Growth YoY-5.42%Latest quarter
Sales Growth YoY34.55%Latest quarter
Sales CAGR 5Y16.43%5 year compound
Profit CAGR 5Y12.94%5 year compound
📋

Quarterly Performance

YoY Profit Growth-5.42%
⚠️ Mild contraction
YoY Sales Growth+34.55%
🔥 Exceptional growth
OPM 5Y Average
Operating profit margin
25.29%
EPS Growth 5Y
4.60%
Interest Coverage
Higher = safer debt servicing
3.46
ROE
6.48%
ROCE
8.54%
💡

Growth Analysis

Sakar Healthcare Ltd reported YoY profit growth of -5.42% and revenue growth of 34.55% in the latest quarter. Mild profit contraction — investigate if one-time or structural. Over 5 years, sales compounded at 16.43% and profits at 12.94% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.